FDA Bioequivalence Study On Metoprolol Shows Emerging Generic Investigation Strategy
This article was originally published in The Pink Sheet Daily
Executive Summary
Outside research project launches after FDA does not find a safety signal in its internal investigation into generic versions of AstraZeneca’s Toprol XL.
You may also be interested in...
Sentinel May Expand To Generic Equivalence Studies
Tool being designed for rapid queries of US Sentinel data to consider generic drug switches, potentially spot equivalence problems.
Sentinel May Expand To Generic Equivalence Studies
Tool being designed for rapid queries of US Sentinel data to consider generic drug switches, potentially spot equivalence problems.
Watson’s Bupropion XL Undone By Outlier Patient, Bankrupt CRO
After long delay, FDA quietly reveals second Wellbutrin generic deemed not therapeutically equivalent; ex-Office of Generic Drugs official predicts FDA will tighten criteria for extrapolating data to higher generic strengths.